ResMed Chairman & CEO Amends Form 4 Beneficial Ownership Total

Executive Summary

On October 1, 2026, ResMed Inc. ($RMD) filed an amended Form 4 (Form 4/A) on behalf of Chairman and Chief Executive Officer Michael J. Farrell. The amendment pertains to the original filing submitted on September 10, 2026, with an original transaction period of September 8, 2026. The amendment was filed solely to correct the reported post-transaction beneficial ownership figures.

Transaction & Holding Breakdown

• Filing Nature: Administrative amendment; no new market sales, purchases, or derivative exercises occurred.
• Reported Direct Ownership: 479,803 shares of ResMed Common Stock held directly.
• Reported Indirect Ownership: 2,090 shares held indirectly through the Lisette and Michael Farrell Family Trust.
• Reason for Filing: Footnote 1 specifies that this Form 4/A was submitted solely to adjust the number of shares beneficially owned following the transaction originally reported on September 10, 2026, leaving the underlying transaction unchanged.

Market Impact & Significance

This filing carries Low trading significance. It represents a routine clerical correction to beneficial ownership balances rather than new open-market buying or selling activity by executive leadership.